Back to today’s briefing

Story perspectives

Trump's Study on Child Meds Sparks Controversy and Concerns

2/21/2025

50 10

Summary

Story summary

President Trump has launched a study on the impact of antidepressants and obesity medications in children, with Robert F. Kennedy Jr. at the helm. Critics warn that branding these medications as a "threat" undermines their proven benefits and risks stigmatizing essential mental health treatments, which are most effective when paired with therapy.

1 of 1

Story summary

President Trump has launched a study on the impact of antidepressants and obesity medications in children, with Robert F. Kennedy Jr. at the helm. Critics warn that branding these medications as a "threat" undermines their proven benefits and risks stigmatizing essential mental health treatments, which are most effective when paired with therapy.